REUTERS: The U.S. Food and Drug Administration (FDA) said it found adulteration and “significant violations” of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd’s plant in Puducherry in south India.Strides shares fell 5per cent in early trade on Wednesday.The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16.”Our investigator observed discarded CGMP documents and evidence of uncontrolled shredding of documents,” it said.The FDA’s warning letter (https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strides-pharma-science-limited-576722-07012019) dated July 1, comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr.Reddy’s Laboratories Ltd were named in a U.S. lawsuit against Israeli drugmaker Teva Pharmaceutical Industries Ltd accusing it of conspiring to inflate drug prices and stifle competition for generic drugs.Last month, Aurobindo Pharma Ltd was warned (https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aurobindo-pharma-limited-577033-06202019) by the FDA for ignoring impurities in an active ingredient it produced. Hyderabad-based Aurobindo recalled contaminated valsartan in January and in March.The destruction of quality-control paperwork and a lack of adequate documentation that its medicines are safe “raise questions about the effectiveness” of Strides’s quality unit “and the integrity and accuracy” of its data, Francis Godwin, director of the FDA’s Office of Manufacturing Quality, wrote in the letter.On July 2,… Read full this story
- Dog Food Recall: FDA Finds Deadly Pet Euthanasia in Several Common Brands
- Three Pakistani Soldiers Killed and 2 Injured in Ceasefire Violation in Jammu and Kashmir
- Covid-19 could fundamentally change India’s political economy
- Before India’s election, voters feed on false information
- How COVID-19 could change India's political economy
- Seven home-quarantine violators sent to centre
- FDA changes boost alcohol for sanitizer from ethanol makers
- FDA calls for heartburn drug Zantac to be pulled from market immediately
- Opinion: Covid-19 impact on Indian economy and the auto industry - What’s ahead of us?
- Can Covid spread after symptoms end?
FDA finds 'significant violations' at India's Strides plant have 332 words, post on www.channelnewsasia.com at July 16, 2019. This is cached page on wBlogs. If you want remove this page, please contact us.